SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001564590-21-017467
Filing Date
2021-04-02
Accepted
2021-04-02 13:29:05
Documents
5
Period of Report
2021-05-25

Document Format Files

Seq Description Document Type Size
1 PRE 14A onct-pre14a_20210525.htm PRE 14A 986533
2 GRAPHIC g1chpm1nl3hd000003.jpg GRAPHIC 519667
3 GRAPHIC g1chpm1nl3hd000004.jpg GRAPHIC 224569
4 GRAPHIC g1chpm1nl3hd000001.jpg GRAPHIC 22350
5 GRAPHIC g1chpm1nl3hd000002.jpg GRAPHIC 22350
  Complete submission text file 0001564590-21-017467.txt   2073838
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-50549 | Film No.: 21801381
SIC: 2834 Pharmaceutical Preparations